205 related articles for article (PubMed ID: 26711606)
21. A comparison of epidemiologic, histologic, and virologic studies on Hodgkin's disease in western Kenya and Nagasaki, Japan.
Kusuda M; Toriyama K; Kamidigo NO; Itakura H
Am J Trop Med Hyg; 1998 Nov; 59(5):801-7. PubMed ID: 9840602
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells.
Dinand V; Dawar R; Arya LS; Unni R; Mohanty B; Singh R
Eur J Cancer; 2007 Jan; 43(1):161-8. PubMed ID: 17113770
[TBL] [Abstract][Full Text] [Related]
23. Comparison of three methods for the detection of Epstein-Barr virus in Hodgkin's lymphoma in paraffin-embedded tissues.
Qi ZL; Han XQ; Hu J; Wang GH; Gao JW; Wang X; Liang DY
Mol Med Rep; 2013 Jan; 7(1):89-92. PubMed ID: 23128841
[TBL] [Abstract][Full Text] [Related]
24. Association between the Epstein-Barr virus and Hodgkin's lymphoma in the North-Eastern part of Hungary: effects on therapy and survival.
Keresztes K; Miltenyi Z; Bessenyei B; Beck Z; Szollosi Z; Nemes Z; Olah E; Illes A
Acta Haematol; 2006; 116(2):101-7. PubMed ID: 16914904
[TBL] [Abstract][Full Text] [Related]
25. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
[TBL] [Abstract][Full Text] [Related]
26. Epstein Barr virus latent membrane protein-1 in Hodgkin's lymphoma in Nigerians.
Adelusola KA; Titiloye NA; Rotimi O; Durosinmi M
Afr Health Sci; 2009 Sep; 9(3):174-8. PubMed ID: 20589147
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma.
Jarrett RF
Leuk Lymphoma; 2003; 44 Suppl 3():S27-32. PubMed ID: 15202522
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of quantitative analysis of plasma epstein- barr virus DNA in patients of Xinjiang Uygur nationality with Hodgkin's Lymphoma.
Li X; Yang SE; Guo YQ; Shen MX; Gu L; Zhao GB; Liu W; Xun T; Bai JP
Asian Pac J Cancer Prev; 2012; 13(12):6379-84. PubMed ID: 23464462
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus and Hodgkin's lymphoma.
Andersson J
Herpes; 2006 May; 13(1):12-6. PubMed ID: 16732997
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr virus viral load and serology in childhood non-Hodgkin's lymphoma and chronic inflammatory conditions in Uganda: implications for disease risk and characteristics.
Orem J; Sandin S; Mbidde E; Mangen FW; Middeldorp J; Weiderpass E
J Med Virol; 2014 Oct; 86(10):1796-803. PubMed ID: 24889739
[TBL] [Abstract][Full Text] [Related]
31. Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma.
Diepstra A; Niens M; Vellenga E; van Imhoff GW; Nolte IM; Schaapveld M; van der Steege G; van den Berg A; Kibbelaar RE; te Meerman GJ; Poppema S
Lancet; 2005 Jun 25-Jul 1; 365(9478):2216-24. PubMed ID: 15978930
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin's lymphoma: a meta-analysis.
Lee JH; Kim Y; Choi JW; Kim YS
Arch Med Res; 2014 Jul; 45(5):417-31. PubMed ID: 24937173
[TBL] [Abstract][Full Text] [Related]
33. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients.
Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S
J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931
[TBL] [Abstract][Full Text] [Related]
34. Improved prognosis of Epstein-Barr virus associated childhood Hodgkin's lymphoma: study of 47 South African cases.
Engel M; Essop MF; Close P; Hartley P; Pallesen G; Sinclair-Smith C
J Clin Pathol; 2000 Mar; 53(3):182-6. PubMed ID: 10823135
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of Epstein-Barr virus infection in head and neck non-Hodgkin's lymphomas in Khorasan, northeast of Iran.
Abadi RZ; Sistani NS; Mohtasham N; Hesari KK; Vaezi T; Pazouki M; Shakeri MT
J Pak Med Assoc; 2013 Jul; 63(7):882-7. PubMed ID: 23901714
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the methods for the detection of Epstein-Barr virus nucleic acids and related gene products in Hodgkin's disease.
Brousset P; Meggetto F; Chittal S; Bibeau F; Arnaud J; Rubin B; Delsol G
Lab Invest; 1993 Oct; 69(4):483-90. PubMed ID: 8231115
[TBL] [Abstract][Full Text] [Related]
37. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
38. [Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection].
Ping LY; Ding N; Shi YF; Sun L; Zheng W; Xie Y; Wang XP; Tu MF; Lin NJ; Ying ZT; Liu WP; Deng LJ; Zhan C; Tian L; Feng LX; Song YQ; Zhu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):78-84. PubMed ID: 24598656
[TBL] [Abstract][Full Text] [Related]
39. Changing patterns in the Epstein-Barr virus (EBV)and Hodgkin lymphoma association in Tunisia.
Dhiab MB; Ziadi S; Saad H; Louhichi T; Trimeche M
Ann Hematol; 2016 Sep; 95(9):1537-43. PubMed ID: 27378019
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
